Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

Medicare’s new GLP-1 Bridge program boosts seniors’ access to weight-loss drugs through 2027—see top GLP-1 and biotech stocks to watch now.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

It might pull it off, provided several things fall right in place.

June 29 (Reuters) - Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and ...

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

A North Carolina-based pharmaceutical company founded in Birmingham plans to close its operations in the Magic City by the end of the year. BioCryst Pharmaceuticals has announced it will discontinue ...